logo
Plus   Neg
Share
Email

Dr. Reddy's Labs Launches Desmopressin Acetate Injection In U.S.

Dr. Reddy's Laboratories Ltd. (RDY) announced Wednesday the launch of Desmopressin Acetate Injection USP, 4 mcg/mL Single-dose Ampules in the U.S. market.

Desmopressin Acetate Injection is a therapeutic equivalent generic version of DDAVP (desmopressin acetate) Injection , 4 mcg/mL, owned by Ferring Pharmaceuticals, Inc., and approved by the U.S. Food and Drug Administration.

The DDAVP (desmopressin acetate) Injection USP brand and generic market had U.S. sales of approximately $20.9 million for the most recent twelve months
ended March 2020 according to IQVIA Health.

Marc Kikuchi, CEO, North America Generics, Dr. Reddy's Laboratories, said, "The launch of Desmopressin Injection demonstrates a strong, growing
collaboration with SunGen Pharma. We look forward to future opportunities with this company."

Dr. Reddy's Desmopressin Acetate Injection USP, 4 mcg/mL is available in a carton of ten 1 mL single-dose ampules.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The New York Times announced its plans to relocate its Hong Kong-based digital news operation to South Korea's Seoul, amid uncertainty following China's tough national security law for the semi-autonomous city. The news organization cited the possible impact of Beijing's new security law to the city's prospects as a hub for journalism in Asia. Search giant Google, Inc. announced Wednesday that it signed an agreement to invest $4.5 billion or 33,737 crore Indian rupees in India's Jio Platforms Ltd, taking a 7.73 percent stake in the company, pending regulatory review in India. This investment by Google values Jio Platforms at an equity value... U.S. Bancorp (USB) reported second quarter earnings per share of $0.41, compared to $1.09, a year ago. On average, 22 analysts polled by Thomson Reuters expected the company to report profit per share of $0.22, for the quarter. Analysts' estimates typically exclude special items. Net income attributable...
Follow RTT